Avinger announced the Company submitted a new 510(k) application to the U.S. Food & Drug Administration for Pantheris LV, its next-generation image-guided atherectomy system for the treatment of larger vessels, such as the SFA and popliteal arteries, where the majority of PAD procedures are performed today.
Published first on TheFly
